The FDA has incredibly detailed guidelines that need to be followed, and a clear process to be followed. This is none of that.
But, the question today is what to do today, a rolling deployment seems pretty hard to argue with.
I'd add, I think it's significant that we haven't seen any administration grandstanding on this specific issue - no Hegseth tweets etc.